Market Overview

UPDATE: Canaccord Genuity Initiates Coverage on Francesca's Holdings Corporation with Buy Rating, $30 PT

Share:
Related FRAN
36 Biggest Movers From Yesterday
Mid-Afternoon Market Update: Francesca's Drops On Earnings Miss; Revance Therapeutics Shares Gain

In a report published Friday, Canaccord Genuity initiated coverage on Francesca's Holdings Corporation (NASDAQ: FRAN) with a Buy rating and $30 price target.

Canaccord Genuity noted, “We believe FRAN's unique business model positions the company to profitably expand its store base. A low-cost, small-footprint store model has translated to EBIT margins in the mid-20% range and one of the specialty retail group's highest ROIC at around 30%. We expect FRAN's boutique feel, driven by a broad and trend-right product assortment, should continue to resonate with customers as the company expands square footage at the highest annual rate among all of the companies in our coverage universe. We estimate double-digit SSS growth will persist in FY13, and we are modeling for EPS of $1.29, which is the highest forecast among sell-side analysts. We are initiating coverage with a BUY rating and DCF-generated price target of $30.”

Francesca's Holdings Corporation closed on Thursday at $23.95.

Latest Ratings for FRAN

DateFirmActionFromTo
Aug 2017FBR CapitalMaintainsNeutral
May 2017FBR CapitalUpgradesUnderperformMarket Perform
Nov 2016NomuraDowngradesBuyNeutral

View More Analyst Ratings for FRAN
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Initiation Analyst Ratings

 

Related Articles (FRAN)

View Comments and Join the Discussion!

Partner Center